Skip to main content
. 2014 Sep 26;9(1):532. doi: 10.1186/1556-276X-9-532

Figure 4.

Figure 4

Hematological analysis after 28-day oral administration of the indicated silica particles. Hematological analysis of (A) white blood cells, (B) lymphocytes, (C) monocytes, (D) granulocytes, (E) platelets, and (F) red blood cells. Values are expressed as mean ± SE (n = 4 to 11). *P < 0.01 and **P < 0.05 compared with the control group; † P < 0.05 compared with the nSP70 group, as indicated by Tukey’s test.